Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Ratios

DiaMedica Therapeutics (DMAC) Other Non Operating Income (2018 - 2019)

DiaMedica Therapeutics' Other Non Operating Income history spans 2 years, with the latest figure at $99000.0 for Q4 2019.

  • For Q4 2019, Other Non Operating Income rose 1514.29% year-over-year to $99000.0; the TTM value through Dec 2019 reached $119000.0, up 275.0%, while the annual FY2025 figure was $1.7 million, 26.82% down from the prior year.
  • Other Non Operating Income reached $99000.0 in Q4 2019 per DMAC's latest filing, up from -$38000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $99000.0 in Q4 2019 to a low of -$39000.0 in Q3 2018.